10.16.19 | Policy
The Unexpected Home for NIH’s Maternal Health Research
In the ongoing quest to ensure women’s inclusion in medical research, many stakeholders consider research involving pregnant and lactating women as the next step forward. At the NIH, these efforts are being led by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
10.11.19 | Policy
SWHR’s Health Care Value Assessment Principles
The U.S. health care system is undergoing transformative changes in the way that it delivers and pays for care. The […]
10.10.19 | Policy
SWHR Policy Advisory Council Meeting
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health. Council members will have an opportunity to work collaboratively to develop policy positions, promote research, and create materials designed benefit women’s health.
8.14.19 | Bone Health
Identifying Knowledge Gaps in Chronic Osteoarthritis Pain in Women
To address the significant impact of chronic pain on women, SWHR will assemble a group of researchers, clinicians, patients, and health care thought leaders for a meeting on chronic pain in women, with a particular focus on osteoarthritic pain.
8.13.19 | Endometriosis
The State of Research and Care for Endometriosis
SWHR brought together a group of patients, clinicians, researchers and other relevant stakeholders for a daylong roundtable meeting to identify unmet needs and knowledge gaps in endometriosis, a condition that affects an estimated 10% of reproductive-age women and causes symptoms such as painful periods and heavy bleeding.
7.24.19 | Policy
SWHR Letter in Support of PRGLAC Task Force
In a letter to the Secretary of Health and Human Services, SWHR expressed its concerns about the future status of […]
7.8.19 | Policy
SWHR Praises FDA Draft Guidance on Lactation Study Design
SWHR sent comments to the Food and Drug Administration (FDA) regarding the agency’s new draft guidance on pre- or post-market […]
7.8.19 | Policy
SWHR Comments on FDA Draft Guidance on Post-Approval Pregnancy Safety Studies
SWHR provided comments to the Food and Drug Administration (FDA) on its recently released draft guidance pertaining pregnancy safety study […]
7.2.19 | Policy
Improving Patient Outcomes: A Look at PCORI’s Research on Women’s Health
When patients and health care providers are forced to make health care decisions without sufficient evidence to inform them, the negative effects can be far-reaching.
6.10.19 | Policy
SWHR Provides Input on ICER Value Assessment Framework
SWHR provided input to the Institute for Clinical and Economic Review (ICER) on the 2020 update to its value assessment […]
